| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |